{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:32:47Z","timestamp":1740123167761,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007351","name":"Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires","doi-asserted-by":"crossref","award":["No 1102-04-16427"],"award-info":[{"award-number":["No 1102-04-16427"]}],"id":[{"id":"10.13039\/501100007351","id-type":"DOI","asserted-by":"crossref"}]},{"name":"MIIC, Link\u00f6ping University","award":["300230"],"award-info":[{"award-number":["300230"]}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["Karolinska Institutet"],"award-info":[{"award-number":["Karolinska Institutet"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003945","name":"Link\u00f6ping University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003945","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Treatment with RNAi against HIV-1 transcripts efficiently inhibits viral replication but induces selection of escape mutants; therefore, the CCR5 coreceptor was suggested as an additional target. Blocking viral and host transcripts improved the antiviral effect. We have used short hairpin RNA (shRNA) targeting the human CCR5 (shCCR5) or the HIV-1 rev (shRev) transcripts to demonstrate distinctive properties of anti-<jats:italic>CCR5<\/jats:italic>shRNA: shCCR5 induced more sustained protection than shRev; partial reduction in CCR5 expression substantially decreased HIV-1 infection, and shCCR5 performed better than shRev in the mixed shRNA-treated and untreated cultures. These observations indicate that CCR5 inhibitors should be conveniently included in HIV-1 gene silencing treatment schedules when only a certain cell fraction is protected to further reduce endogenous virus in a properly ART-treated HIV-1 infected individual.<\/jats:p>","DOI":"10.1007\/s11033-022-07899-9","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T08:07:12Z","timestamp":1663056432000},"page":"11187-11192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Specific properties of shRNA-mediated CCR5 downregulation that enhance the inhibition of HIV-1 infection in combination with shRNA targeting HIV-1 rev"],"prefix":"10.1007","volume":"49","author":[{"given":"Maria E.","family":"Cardona","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1908-5609","authenticated-orcid":false,"given":"Jorma","family":"Hinkula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birger","family":"Christensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"Wahren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdalla J.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. I. Edvard","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Jose","family":"Arteaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,12]]},"reference":[{"key":"7899_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13073-015-0174-y","volume":"7","author":"ML Bobbin","year":"2015","unstructured":"Bobbin ML, Burnett JC, Rossi JJ (2015) RNA interference approaches for treatment of HIV-1 infection. Genome Med 7:50. https:\/\/doi.org\/10.1186\/s13073-015-0174-y","journal-title":"Genome Med"},{"key":"7899_CR2","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1038\/s41467-019-10366-y","volume":"10","author":"PK Dash","year":"2019","unstructured":"Dash PK, Kaminski R, Bella R, Su H, Mathews S et al (2019) Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice. Nat Commun 10:2753. https:\/\/doi.org\/10.1038\/s41467-019-10366-y","journal-title":"Nat Commun"},{"key":"7899_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nbt0303-230","volume":"21","author":"HJ Arteaga","year":"2003","unstructured":"Arteaga HJ, Hinkula J, van Dijk-Hard I, Dilber MS, Wahren B et al (2003) Choosing CCR5 or Rev siRNA in HIV-1. Nat Biotechnol 21:230\u2013231. https:\/\/doi.org\/10.1038\/nbt0303-230","journal-title":"Nat Biotechnol"},{"key":"7899_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0968-0004(03)00142-7","volume":"28","author":"BR Cullen","year":"2003","unstructured":"Cullen BR (2003) Nuclear mRNA export: insights from virology. Trends Biochem Sci 28:419\u2013424. https:\/\/doi.org\/10.1016\/S0968-0004(03)00142-7","journal-title":"Trends Biochem Sci"},{"key":"7899_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/gt.2015.11","volume":"22","author":"E Herrera-Carrillo","year":"2015","unstructured":"Herrera-Carrillo E, Berkhout B (2015) The impact of HIV-1 genetic diversity on the efficacy of a combinatorial RNAi-based gene therapy. Gene Ther 22:485\u2013495. https:\/\/doi.org\/10.1038\/gt.2015.11","journal-title":"Gene Ther"},{"key":"7899_CR6","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/nm1196-1240","volume":"2","author":"Y Huang","year":"1996","unstructured":"Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L et al (1996) The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 2:1240\u20131243. https:\/\/doi.org\/10.1038\/nm1196-1240","journal-title":"Nat Med"},{"key":"7899_CR7","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","volume":"117","author":"K Allers","year":"2011","unstructured":"Allers K, Hutter G, Hofmann J, Loddenkemper C, Rieger K et al (2011) Evidence for the cure of HIV infection by CCR5Delta32\/Delta32 stem cell transplantation. Blood 117:2791\u20132799. https:\/\/doi.org\/10.1182\/blood-2010-09-309591","journal-title":"Blood"},{"key":"7899_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","volume":"568","author":"RK Gupta","year":"2019","unstructured":"Gupta RK, Abdul-Jawad S, McCoy LE, Mok HP, Peppa D et al (2019) HIV-1 remission following CCR5Delta32\/Delta32 haematopoietic stem-cell transplantation. Nature 568:244\u2013248. https:\/\/doi.org\/10.1038\/s41586-019-1027-4","journal-title":"Nature"},{"key":"7899_CR9","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1056\/NEJMc1405805","volume":"371","author":"L Kordelas","year":"2014","unstructured":"Kordelas L, Verheyen J, Beelen DW, Horn PA, Heinold A et al (2014) Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation. N Engl J Med 371:880\u2013882. https:\/\/doi.org\/10.1056\/NEJMc1405805","journal-title":"N Engl J Med"},{"key":"7899_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1006\/viro.2000.0633","volume":"278","author":"B Zuber","year":"2000","unstructured":"Zuber B, Hinkula J, Vodros D, Lundholm P, Nilsson C et al (2000) Induction of immune responses and break of tolerance by DNA against the HIV-1 coreceptor CCR5 but no protection from SIVsm challenge. Virology 278:400\u2013411. https:\/\/doi.org\/10.1006\/viro.2000.0633","journal-title":"Virology"},{"key":"7899_CR11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.addr.2016.03.005","volume":"103","author":"MN Swamy","year":"2016","unstructured":"Swamy MN, Wu H, Shankar P (2016) Recent advances in RNAi-based strategies for therapy and prevention of HIV-1\/AIDS. Adv Drug Deliv Rev 103:174\u2013186. https:\/\/doi.org\/10.1016\/j.addr.2016.03.005","journal-title":"Adv Drug Deliv Rev"},{"key":"7899_CR12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1126\/science.1068999","volume":"296","author":"TR Brummelkamp","year":"2002","unstructured":"Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550\u2013553. https:\/\/doi.org\/10.1126\/science.1068999","journal-title":"Science"},{"key":"7899_CR13","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1128\/JVI.71.5.3932-3939.1997","volume":"71","author":"B Chackerian","year":"1997","unstructured":"Chackerian B, Long EM, Luciw PA, Overbaugh J (1997) Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J Virol 71:3932\u20133939. https:\/\/doi.org\/10.1128\/JVI.71.5.3932-3939.1997","journal-title":"J Virol"},{"key":"7899_CR14","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1128\/JVI.72.4.3394-3400.1998","volume":"72","author":"H Moriuchi","year":"1998","unstructured":"Moriuchi H, Moriuchi M, Fauci AS (1998) Differentiation of promonocytic U937 subclones into macrophagelike phenotypes regulates a cellular factor(s) which modulates fusion\/entry of macrophagetropic human immunodeficiency virus type 1. J Virol 72:3394\u20133400. https:\/\/doi.org\/10.1128\/JVI.72.4.3394-3400.1998","journal-title":"J Virol"},{"key":"7899_CR15","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/00002030-199807000-00009","volume":"12","author":"G Bratt","year":"1998","unstructured":"Bratt G, Leandersson AC, Albert J, Sandstr\u00f6m E, Wahren B (1998) MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals. AIDS 12:729\u2013736. https:\/\/doi.org\/10.1097\/00002030-199807000-00009","journal-title":"AIDS"},{"key":"7899_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s0022-1759(00)00141-1","volume":"238","author":"C Devito","year":"2000","unstructured":"Devito C, Levi M, Broliden K, Hinkula J (2000) Mapping of B-cell epitopes in rabbits immunised with various gag antigens for the production of HIV-1 gag capture ELISA reagents. J Immunol Methods 238:69\u201380. https:\/\/doi.org\/10.1016\/s0022-1759(00)00141-1","journal-title":"J Immunol Methods"},{"key":"7899_CR17","doi-asserted-by":"crossref","unstructured":"Motulsky H, Christopoulos A (2003) Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting. GraphPad Software Inc San Diego CA. http:\/\/www.graphpad.com\/","DOI":"10.1093\/oso\/9780195171792.001.0001"},{"key":"7899_CR18","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1097\/01.aids.0000233570.51899.e2","volume":"20","author":"YL Lin","year":"2006","unstructured":"Lin YL, Mettling C, Portales P, Reant B, Robert-Hebmann V et al (2006) The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling. Aids 20:1369\u20131377. https:\/\/doi.org\/10.1097\/01.aids.0000233570.51899.e2","journal-title":"Aids"},{"key":"7899_CR19","doi-asserted-by":"publisher","first-page":"10455","DOI":"10.1128\/JVI.75.21.10455-10459.2001","volume":"75","author":"D Kwa","year":"2001","unstructured":"Kwa D, Vingerhoed J, Boeser-Nunnink B, Broersen S, Schuitemaker H (2001) Cytopathic effects of non-syncytium-inducing and syncytium-inducing human immunodeficiency virus type 1 variants on different CD4(+)-T-cell subsets are determined only by coreceptor expression. J Virol 75:10455\u201310459. https:\/\/doi.org\/10.1128\/JVI.75.21.10455-10459.2001","journal-title":"J Virol"},{"key":"7899_CR20","doi-asserted-by":"publisher","first-page":"e1002634","DOI":"10.1371\/journal.ppat.1002634","volume":"8","author":"IA Abela","year":"2012","unstructured":"Abela IA, Berlinger L, Schanz M, Reynell L, Gunthard HF et al (2012) Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies. PLoS Pathog 8:e1002634. https:\/\/doi.org\/10.1371\/journal.ppat.1002634","journal-title":"PLoS Pathog"},{"key":"7899_CR21","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.bone.2008.11.011","volume":"44","author":"M Wu","year":"2009","unstructured":"Wu M, Hesse E, Morvan F, Zhang JP, Correa D et al (2009) Zfp521 antagonizes Runx2, delays osteoblast differentiation in vitro, and promotes bone formation in vivo. Bone 44:528\u2013536. https:\/. \/doi.org\/S8756-3282(08)00906-X [pii]","journal-title":"Bone"},{"key":"7899_CR22","doi-asserted-by":"publisher","first-page":"11964","DOI":"10.1128\/jvi.77.22.11964-11972.2003","volume":"77","author":"MT Lee","year":"2003","unstructured":"Lee MT, Coburn GA, McClure MO, Cullen BR (2003) Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J Virol 77:11964\u201311972. https:\/\/doi.org\/10.1128\/jvi.77.22.11964-11972.2003","journal-title":"J Virol"},{"key":"7899_CR23","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.cell.2008.06.034","volume":"134","author":"P Kumar","year":"2008","unstructured":"Kumar P, Ban HS, Kim SS, Wu H, Pearson T et al (2008) T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134:577\u2013586. https:\/\/doi.org\/10.1016\/j.cell.2008.06.034","journal-title":"Cell"},{"key":"7899_CR24","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00063-18","author":"M Ashokkumar","year":"2018","unstructured":"Ashokkumar M, Aralaguppe SG, Tripathy SP, Hanna LE, Neogi U (2018) Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses. J Virol. https:\/\/doi.org\/10.1128\/JVI.00063-18","journal-title":"J Virol"},{"key":"7899_CR25","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/jama.296.7.815","volume":"296","author":"MM Lederman","year":"2006","unstructured":"Lederman MM, Penn-Nicholson A, Cho M, Mosier D (2006) Biology of CCR5 and its role in HIV infection and treatment. JAMA 296:815\u2013826. https:\/\/doi.org\/10.1001\/jama.296.7.815","journal-title":"JAMA"},{"key":"7899_CR26","doi-asserted-by":"publisher","first-page":"36ra43","DOI":"10.1126\/scitranslmed.3000931","volume":"2","author":"DL DiGiusto","year":"2010","unstructured":"DiGiusto DL, Krishnan A, Li L, Li H, Li S et al (2010) RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma. Sci Transl Med 2:36ra43. https:\/\/doi.org\/10.1126\/scitranslmed.3000931","journal-title":"Sci Transl Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07899-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07899-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07899-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T22:01:28Z","timestamp":1701036088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07899-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,12]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["7899"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07899-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2022,9,12]]},"assertion":[{"value":"9 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}